Abstract:The low water solubility of pharmacoactive molecules limits their pharmacological potential, but the solubility parameter cannot compromise, and so different approaches are employed to enhance their bioavailability. Pharmaceutically active molecules with low solubility convey a higher risk of failure for drug innovation and development. Pharmacokinetics, pharmacodynamics, and several other parameters, such as drug distribution, protein binding and absorption, are majorly affected by their solubility. Among all pharmaceutical dosage forms, oral dosage forms cover more than 50%, and the drug molecule should be water-soluble. For good therapeutic activity by the drug molecule on the target site, solubility and bioavailability are crucial factors. The pharmaceutical industry's screening programs identified that around 40% of new chemical entities (NCEs) face various difficulties at the formulation and development stages. These pharmaceuticals demonstrate less solubility and bioavailability. Enhancement of the bioavailability and solubility of drugs is a significant challenge in the area of pharmaceutical formulations. According to the Classification of Biopharmaceutics, Class II and IV drugs (APIs) exhibit poor solubility, lower bioavailability, and less dissolution. Various technologies are discussed in this article to improve the solubility of poorly water-soluble drugs, for example, the complexation of active molecules, the utilization of emulsion formation, micelles, microemulsions, cosolvents, polymeric micelle preparation, particle size reduction technologies, pharmaceutical salts, prodrugs, the solid-state alternation technique, soft gel technology, drug nanocrystals, solid dispersion methods, crystal engineering techniques and nanomorph technology. This review mainly describes several other advanced methodologies for solubility and bioavailability enhancement, such as crystal engineering, micronization, solid dispersions, nano sizing, the use of cyclodextrins, solid lipid nanoparticles, colloidal drug delivery systems and drug conjugates, referring to a number of appropriate research reports.

"Enhancing Oral Drug Absorption: Overcoming Physiological and Pharmaceutical Barriers for Improved Bioavailability"

Advances in Oral Drug Delivery

Overall Review On Permeation Enhancers in Drug Delivery Systems

Oral Bioavailability: Issues and Solutions via Nanoformulations

Advances in Oral Drug Delivery Systems: Challenges and Opportunities

Oral drug delivery platforms for biomedical applications

Recent innovations in oral drug delivery systems: Examining current challenges and future opportunities for enhanced therapeutic efficacy

A Comprehensive Review of Challenges in Oral Drug Delivery Systems and Recent Advancements in Innovative Design Strategies

Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals

Drug complexes: Perspective from Academic Research and Pharmaceutical Market

Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability

Drug Bioavailability Enhancing Agents of Natural Origin (Bioenhancers) that Modulate Drug Membrane Permeation and Pre-Systemic Metabolism

Nanosized Drug Delivery for Enhancement of Oral Bioavailability

Carrier Systems for Advanced Drug Delivery: Improving Drug Solubility/Bioavailability and Administration Routes

Mechanisms of Nanoparticle Transport across Intestinal Tissue: An Oral Delivery Perspective

Polymeric nanoparticle drug delivery technologies for oral delivery applications

A Window for Enhanced Oral Delivery of Therapeutics via Lipid Nanoparticles

Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics

Nanostructured Lipid Carriers for Improved Delivery of Therapeutics via the Oral Route

Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs

A Review of Key Factors and Approaches